HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells.

AbstractPURPOSE:
Hemochromatosis is a disorder of iron overload arising mostly from mutations in HFE. HFE is expressed in retinal pigment epithelium (RPE), and Hfe(-/-) mice develop age-related iron accumulation and retinal degeneration associated with RPE hyperproliferation. Here, the mechanism underlying the hyperproliferative phenotype in RPE was investigated.
METHODS:
Cellular senescence was monitored by β-galactosidase activity. Gene expression was monitored by real-time PCR. Survivin was analyzed by Western blot and immunofluorescence. Migration and invasion were monitored using appropriate kits. Glucose transporters (GLUTs) were monitored by 3-O-methyl-D-glucose uptake. Histone deacetylases (HDACs) were studied by monitoring catalytic activity and acetylation status of histones H3/H4.
RESULTS:
Hfe(-/-) RPE cells exhibited slower senescence rate and higher survivin expression than wild type cells. Hfe(-/-) cells migrated faster and showed greater glucose uptake and increased expression of GLUTs. The expression of HDACs and DNA methyltransferase (DNMTs) also was increased. Similarly, RPE cells from hemojuvelin (Hjv)-knockout mice, another model of hemochromatosis, also had increased expression of GLUTs, HDACs, and DNMTs. The expression of Slc5a8 was decreased in Hfe(-/-) RPE cells, but treatment with a DNA methylation inhibitor restored the transporter expression, indicating involvement of DNA methylation in the silencing of Slc5a8 in Hfe(-/-) cells.
CONCLUSIONS:
RPE cells from iron-overloaded mice exhibit several features of tumor cells: decreased senescence, enhanced migration, increased glucose uptake, and elevated levels of HDACs and DNMTs. These features are seen in Hfe(-/-) RPE cells as well as in Hjv(-/-) RPE cells, providing a molecular basis for the hyperproliferative phenotype of Hfe(-/-) and Hjv(-/-) RPE cells.
AuthorsJaya P Gnana-Prakasam, Rajalakshmi Veeranan-Karmegam, Veena Coothankandaswamy, Sushma K Reddy, Pamela M Martin, Muthusamy Thangaraju, Sylvia B Smith, Vadivel Ganapathy
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 54 Issue 1 Pg. 63-71 (Jan 07 2013) ISSN: 1552-5783 [Electronic] United States
PMID23169885 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Amino Acid Transport Systems
  • Birc5 protein, mouse
  • Cation Transport Proteins
  • Hemochromatosis Protein
  • Hfe protein, mouse
  • Histocompatibility Antigens Class I
  • Inhibitor of Apoptosis Proteins
  • Membrane Proteins
  • Monocarboxylic Acid Transporters
  • Plasma Membrane Neurotransmitter Transport Proteins
  • Repressor Proteins
  • Slc5a8 protein, mouse
  • Slc6A14 protein, mouse
  • Survivin
  • Glucose
Topics
  • Amino Acid Transport Systems (genetics)
  • Animals
  • Cation Transport Proteins (genetics)
  • Cell Movement (physiology)
  • Cell Transformation, Neoplastic (pathology)
  • Cellular Senescence (physiology)
  • DNA Methylation (physiology)
  • Disease Progression
  • Eye Neoplasms (genetics, pathology, physiopathology)
  • Female
  • Glucose (pharmacokinetics)
  • Hemochromatosis (genetics, pathology, physiopathology)
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I (genetics)
  • Inhibitor of Apoptosis Proteins (metabolism)
  • Male
  • Membrane Proteins (genetics)
  • Mice
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Nude
  • Monocarboxylic Acid Transporters
  • Phenotype
  • Plasma Membrane Neurotransmitter Transport Proteins (genetics)
  • Primary Cell Culture
  • Repressor Proteins (metabolism)
  • Retinal Pigment Epithelium (pathology, physiopathology)
  • Survivin
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: